Codes / ICD10CM / H04.141

H04.141 Primary lacrimal gland atrophy, right lacrimal gland

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Primary Lacrimal Gland Atrophy, Right Lacrimal Gland (ICD-10 code: H04.141)

Summary

Primary lacrimal gland atrophy, right lacrimal gland, is a condition involving the progressive degeneration or shrinkage of the right lacrimal gland, which is responsible for tear production. This can lead to reduced tear output, resulting in dry eye symptoms or ocular discomfort. The term "primary" indicates the atrophy occurs without an identifiable underlying cause, distinguishing it from secondary atrophy linked to other diseases or trauma.

Causes

The exact cause of primary lacrimal gland atrophy is not fully understood. It is thought to involve age-related changes, autoimmune processes, or degenerative mechanisms affecting the gland tissue. Unlike secondary atrophy, no specific infection, trauma, or systemic disease is identified as the trigger in primary cases.

Risk Factors

Risk factors may include advanced age, as glandular tissue naturally declines over time. Genetic predisposition or a history of autoimmune conditions could also increase susceptibility, though specific associations are not well established for primary cases.

Symptoms

Symptoms typically include persistent dryness, burning, or grittiness in the right eye. Patients may experience reduced tear production, leading to discomfort, redness, or a sensation of foreign bodies. Vision may be temporarily blurred due to insufficient lubrication.

Diagnosis

Diagnosis involves a clinical evaluation, including a physical examination of the eye and lacrimal gland. Tests to assess tear production, such as the Schirmer test, may be performed. Imaging studies like MRI or CT scans can help visualize the gland's structure and rule out other conditions.

Treatment Options

Treatment focuses on managing symptoms, such as using artificial tears or lubricating eye drops to alleviate dryness. In some cases, anti-inflammatory medications or immunosuppressants may be considered if an autoimmune component is suspected. Regular monitoring is recommended to address any changes in symptoms.

Prognosis and Follow-Up

The prognosis for primary lacrimal gland atrophy is generally stable, with symptoms managed through ongoing care. Regular follow-up with an eye care professional is important to monitor tear production and adjust treatment as needed. The condition typically progresses slowly, and most patients maintain functional vision with appropriate management.

Complications

Complications may include chronic dry eye, which can increase the risk of corneal abrasions or infections. Severe dryness may also lead to discomfort or visual disturbances if left untreated.

Lifestyle & Prevention

Lifestyle measures to manage symptoms include using humidifiers to reduce environmental dryness, avoiding smoke or irritants, and taking breaks during screen time to reduce eye strain. Protective eyewear in windy or dry conditions can help retain moisture.

When to Seek Professional Help

Seek medical attention if dry eye symptoms worsen, vision changes occur, or there is increased redness, pain, or discharge. These may indicate complications or other underlying issues requiring prompt evaluation.

Tips for Medical Coders

When coding H04.141, ensure the documentation specifies "primary" atrophy and the right lacrimal gland to distinguish it from bilateral or secondary cases. Verify that no underlying cause (e.g., trauma, infection, or systemic disease) is documented, as this would alter coding. Accurate clinical details support correct code assignment.

Book a walkthrough

H04.141 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.